These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pharmacokinetics and dosage regimen of ciprofloxacin following single intramuscular administration in Teddy goats. Iqbal Z, Javed I, Basit A, Jan I, Khan AA. Pak J Pharm Sci; 2011 Jan; 24(1):69-74. PubMed ID: 21190922 [Abstract] [Full Text] [Related]
7. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease. Conte JE, Golden JA, McIver M, Little E, Zurlinden E. Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873 [Abstract] [Full Text] [Related]
9. Pharmacokinetics of ofloxacin in drug-resistant tuberculosis. Chulavatnatol S, Chindavijak B, Chierakul N, Klomsawat D. J Med Assoc Thai; 2003 Aug; 86(8):781-8. PubMed ID: 12948278 [Abstract] [Full Text] [Related]
10. Characterization of the pharmacokinetic disposition of levofloxacin in stallions after intravenous and intramuscular administration. Goudah A, Abo El-Sooud K, Shim JH, Shin HC, Abd El-Aty AM. J Vet Pharmacol Ther; 2008 Oct; 31(5):399-405. PubMed ID: 19000258 [Abstract] [Full Text] [Related]
11. [Determination of levofloxacin in plasma and cerebrospinal fluid with HPLC and its pharmacokinetics in patients undergoing neurosurgical operations]. Luo S, Lei J, Zhang R, Cai H, Li R. Yao Xue Xue Bao; 1998 Dec; 33(12):937-40. PubMed ID: 12016861 [Abstract] [Full Text] [Related]
12. Structure-tissue distribution relationship based on physiological pharmacokinetics for NY-198, a new antimicrobial agent, and the related pyridonecarboxylic acids. Okezaki E, Terasaki T, Nakamura M, Nagata O, Kato H, Tsuji A. Drug Metab Dispos; 1988 Dec; 16(6):865-74. PubMed ID: 2907467 [Abstract] [Full Text] [Related]
13. Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem. Conte JE, Golden JA, Kelley MG, Zurlinden E. Int J Antimicrob Agents; 2005 Dec; 26(6):449-56. PubMed ID: 16280244 [Abstract] [Full Text] [Related]
14. Pharmacokinetics and milk penetration of difloxacin after intravenous, subcutaneous and intramuscular administration to lactating goats. Marín P, Escudero E, Fernández-Varón E, Cárceles CM. J Vet Pharmacol Ther; 2007 Feb; 30(1):74-9. PubMed ID: 17217405 [Abstract] [Full Text] [Related]
16. Pharmacokinetics and tissue distribution of ofloxacin in human subjects during a multiple dose regimen. De Bernardis E, Bonaccorsi S, Carlino S, Picari M, Rizza V. Int J Clin Pharmacol Res; 1988 Feb; 8(4):239-45. PubMed ID: 3182113 [Abstract] [Full Text] [Related]
18. The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration. Davis JL, Papich MG, Weingarten A. J Vet Pharmacol Ther; 2006 Jun; 29(3):191-7. PubMed ID: 16669863 [Abstract] [Full Text] [Related]
19. Effect of fever on pharmacokinetics and dosage regimen of intramuscularly administered amikacin in goats. Agrawal AK, Singh SD, Jayachandran C. J Vet Sci; 2001 Aug; 2(2):91-6. PubMed ID: 14614277 [Abstract] [Full Text] [Related]
20. Determinant of the distribution volume at steady state for novel quinolone pazufloxacin in rats. Hayakawa H, Takagi K, Takano YF, Kawamura Y, Tsuji A. J Pharm Pharmacol; 2002 Sep; 54(9):1229-36. PubMed ID: 12356277 [Abstract] [Full Text] [Related] Page: [Next] [New Search]